Cat. No. | Product name | CAS No. |
DC42463 |
Thalidomide-NH-CH2-COOH
Thalidomide-NH-CH2-COOH is the Thalidomide-based cereblon ligand used in the recruitment of CRBN protein. Thalidomide-NH-CH2-COOH can be connected to the ligand for protein by a linker to form PROTACs, such as THAL-SNS-032. |
927670-97-1 |
DC42464 |
CRBN modulator-1
Featured
CRBN modulator-1, a Thalidomide analog and a CRBN modulator extracted from WO2020006262A1, compound 10, has an IC50 of 3.5 μM and a Ki of 0.98 μM. |
2407829-65-4 |
DC42552 |
Pomalidomide-PEG2-azide
Pomalidomide-PEG2-azide is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology. |
2267306-14-7 |
DC42553 |
Pomalidomide-PEG3-azide
Pomalidomide-PEG3-azide is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. |
2267306-15-8 |
DC42554 |
Pomalidomide 4'-PEG5-acid
Pomalidomide 4'-PEG5-acid (Pomalidomide-PEG5-CO2H) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 5-unit PEG linker used in PROTAC technology. |
2139348-63-1 |
DC42555 |
(S,R,S)-AHPC-PEG5-Boc
(S,R,S)-AHPC-PEG5-Boc is a E3 ligase ligand-linker conjugate that incorporates the (S,R,S)-AHPC based VHL ligand and a linker used for Cdc20 degrader CP5V. |
|
DC42556 |
Thalidomide-NH-PEG4-COOH
Thalidomide-NH-PEG4-COOH is an E3 ligase ligand-linker conjugate which can be used for synthesizing dCBP-1. dCBP-1 is a potent and selective heterobifunctional degrader of p300/CBP. |
2412056-48-3 |
DC42559 |
Piperidine-GNE-049-N-Boc
Piperidine-GNE-049-N-Boc is a ligand for target protein for PROTAC of dCBP-1. dCBP-1 is a potent and selective heterobifunctional degrader of p300/CBP. |
1936431-36-5 |
DC43971 |
Thalidomide-NH-PEG4-Ms
Thalidomide-NH-PEG4-Ms is an E3 ligase ligand-linker conjugate that incorporates Thalidomide based cereblon ligand and a linker used for PROTAC BCL-XL degrader XZ739. |
2140807-24-3 |
DC43972 |
Thalidomide-NH-C2-PEG3-OH
Thalidomide-NH-C2-PEG3-OH is an E3 ligase ligand-linker conjugate that incorporates Thalidomide based cereblon ligand and a linker used for PROTAC BCL-XL degrader XZ739. |
2140807-23-2 |
DC43998 |
Tos-O-C4-NH-Boc
Tos-O-C4-NH-Boc is an alkyl ether-based PROTAC linker can be used in the synthesis of PROTACs, such as BSJ-03-204 |
180851-50-7 |
DC51006 |
Lenalidomide-4-OH
Featured
A Novel PROTACs building block. |
1061604-41-8 |
DC51007 |
Lenalidomide-5-aminomethyl hydrochloride
Featured
Lenalidomide-5-aminomethyl hydrochloride is the Lenalidomide-based cereblon (CRBN) ligand used in the recruitment of CRBN protein. Lenalidomide-5-aminomethyl hydrochloride can be connected to the ligand for protein by a linker to form PROTAC |
1158264-69-7 |
DC51010 |
CID 138454799
Featured
ERD-308 is a highly potent PROTAC degrader of estrogen receptor (ER) for ER positive breast cancer treatment. |
2320561-35-9 |
DC44010 |
BOC-NH-PEG2-propene
BOC-NH-PEG2-propene is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
2410236-85-8 |
DC44011 |
Propenyl-PEG3-Propenyl
Propenyl-PEG3-Propenyl is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
90736-68-8 |
DC44014 |
H2N-PEG2-CH2COOtBu
H2N-PEG2-CH2COOtBu is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
1122484-77-8 |
DC44016 |
Benzyl-PEG2-acid
Benzyl-PEG2-acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
91555-65-6 |
DC44022 |
Hydroxy-PEG4-methyl acetate
Hydroxy-PEG4-methyl acetate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
77303-64-1 |
DC44024 |
Boc-NH-PEG-Thiol (MW 10000)
Boc-NH-PEG-Thiol (MW 10000) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. |
|
DC44025 |
m-PEG750-Br
m-PEG750-Br is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs. |
|
DC44026 |
NH2-PEG-Strt (MW 10000)
NH2-PEG-Strt (MW 10000) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. |